Insider · CIK 0001810701

Palasis Maria

Reports to the SEC for 2 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001810701

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-21	BBNXBeta Bionics, Inc.A Award	Director	AAward	+17K sh	—	—	29,397
2026-04-01	LYRALyra Therapeutics, Inc.D Disposition to Issuer	Director, Principal Executive Officer	DDisposition to Issuer	−2,000 sh	—	—	1,094,733
2026-01-13	BBNXBeta Bionics, Inc.A Award	Director	AAward	+3,997 sh	—	—	12,432
2026-01-06	LYRALyra Therapeutics, Inc.S Sale	Director, Principal Executive Officer	SSale	−1,702 sh	$3.36	−$5,725.528	1,096,733
2025-12-01	BBNXBeta Bionics, Inc.S Sale	Director	SSale	−906 sh	$29.33	−$26.6K	8,935
2025-12-01	BBNXBeta Bionics, Inc.S Sale	Director	SSale	−500 sh	$29.96	−$15K	8,435
2025-10-31	BBNXBeta Bionics, Inc.S Sale	Director	SSale	−1,287 sh	$26.86	−$34.6K	9,960
2025-10-31	BBNXBeta Bionics, Inc.S Sale	Director	SSale	−119 sh	$27.45	−$3,266.574	9,841
2025-10-01	LYRALyra Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Principal Executive Officer	AAward	+3,667 sh	—	—	7,333
2025-07-10	LYRALyra Therapeutics, Inc.S Sale	Director, Principal Executive Officer	SSale	−1,565 sh	$8.91	−$13.9K	1,098,435
2025-03-15	BBNXBeta Bionics, Inc.A Award	Director	AAward	+11.2K sh	—	—	11,247
2025-01-31	BBNXBeta Bionics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+9,137 sh	—	—	9,137
2025-01-08	LYRALyra Therapeutics, Inc.A Award	Director, Principal Executive Officer	AAward	+800K sh	—	—	1,100,000
2024-12-09	LYRALyra Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, Principal Executive Officer	AAward	+183K sh	—	—	183,333
2024-10-16	LYRALyra Therapeutics, Inc.A Award	Director, Principal Executive Officer	AAward	+300K sh	—	—	300,000
2024-03-18	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director, Principal Executive Officer	AAward	+500K sh	—	—	500,000
2023-06-15	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director, Principal Executive Officer	AAward	+150K sh	—	—	150,000
2023-06-15	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director, Principal Executive Officer	AAward	+150K sh	—	—	150,000
2023-01-31	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director, Principal Executive Officer	AAward	+250K sh	—	—	250,000
2022-02-16	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director, Principal Executive Officer	AAward	+175K sh	—	—	175,000
2022-02-12	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director, Principal Executive Officer	AAward	+127K sh	—	—	127,400
2021-02-08	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director, Principal Executive Officer	AAward	+120K sh	—	—	120,000
2020-04-30	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director, Principal Executive Officer	AAward	+326K sh	—	—	326,303

Recent filings

Accepted (ET)
May 264
Palasis Maria0001810701-26-000003
SEC(opens sec.gov)
Apr 34
Palasis Maria0001193125-26-142100
SEC(opens sec.gov)
Jan 144
Palasis Maria0001810701-26-000002
SEC(opens sec.gov)
Jan 84
Palasis Maria0001193125-26-007751
SEC(opens sec.gov)
Dec 24
Palasis Maria0001810701-25-000007
SEC(opens sec.gov)
Nov 54
Palasis Maria0001810701-25-000005
SEC(opens sec.gov)
Oct 34
Palasis Maria0001193125-25-230193
SEC(opens sec.gov)
Jul 144
Palasis Maria0000950170-25-095682
SEC(opens sec.gov)
Mar 184
Palasis Maria0001415889-25-008536
SEC(opens sec.gov)
Feb 34
Palasis Maria0001415889-25-002821
SEC(opens sec.gov)
Jan 104
Palasis Maria0000950170-25-004167
SEC(opens sec.gov)
Dec 114
Palasis Maria0000950170-24-135537
SEC(opens sec.gov)
Oct 184
Palasis Maria0000950170-24-115597
SEC(opens sec.gov)
Mar 204
Palasis Maria0000950170-24-034348
SEC(opens sec.gov)
Jul 124/A
Palasis Maria0000950170-23-032707
SEC(opens sec.gov)
Jun 264
Palasis Maria0000950170-23-029918
SEC(opens sec.gov)
Feb 24
Palasis Maria0000899243-23-003510
SEC(opens sec.gov)
Feb 184
Palasis Maria0000899243-22-007042
SEC(opens sec.gov)

Companies

Address

C/O BETA BIONICS, INC. 11 HUGHES

IRVINE, CA, 92618